Management of Nasal Colonization of Gram-Positive Bacilli
Indications for Treatment
- The Infectious Diseases Society of America recommends against routine decolonization of asymptomatic carriers, but treatment may be indicated for recurrent skin and soft tissue infections, ongoing household transmission, pre-operative screening and decolonization, or following treatment of active infection 1
- Treatment should only be pursued in specific scenarios, including recurrent skin and soft tissue infections that persist despite optimizing wound care and hygiene measures 1, 3
- Ongoing household transmission among close contacts despite hygiene interventions is another indication for treatment 1, 3
- Pre-operative screening and decolonization before high-risk surgeries, such as cardiothoracic or orthopedic surgeries, is also recommended 4, 5
Decolonization Protocol
- The European Society of Clinical Microbiology and Infectious Diseases recommends intranasal mupirocin 2% ointment applied to both anterior nares twice daily for 5-10 days as the primary decolonization regimen 1, 2, 3
- For patients with persistent recurrences, a combination of mupirocin with body decolonization using chlorhexidine gluconate 2% body wash or dilute bleach baths may be effective 1, 2, 3
Essential Concurrent Measures
- Decolonization fails without concurrent hygiene interventions, including keeping draining wounds covered, practicing hand hygiene, avoiding sharing personal items, and cleaning high-touch surfaces 1, 3
- Treating interdigital toe space infections or maceration is also essential to eliminate colonization reservoirs 1
Household Contact Management
- Treating both the patient and household contacts together results in fewer recurrences than treating the patient alone 1, 3
- Asymptomatic household contacts may be considered for decolonization only when ongoing transmission is documented despite hygiene measures 1, 3
Critical Pitfalls to Avoid
- High-level mupirocin resistance has been reported in some S. aureus strains, and prolonged or indiscriminate use promotes resistance without clinical benefit 1, 2, 3
- Recolonization occurs in 40-60% of patients within 3 months after decolonization, and mupirocin may not conclusively prevent infections in community settings 1, 3